Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BB7F
|
|||
| Former ID |
DNC008453
|
|||
| Drug Name |
4-butyl-N-(isoquinolin-5-yl)benzamide
|
|||
| Synonyms |
CHEMBL407762
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H20N2O
|
|||
| Canonical SMILES |
CCCCC1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C=CN=C3
|
|||
| InChI |
1S/C20H20N2O/c1-2-3-5-15-8-10-16(11-9-15)20(23)22-19-7-4-6-17-14-21-13-12-18(17)19/h4,6-14H,2-3,5H2,1H3,(H,22,23)
|
|||
| InChIKey |
FBFHYVLRXNNMSE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transient receptor potential cation channel V1 (TRPV1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Inflammatory mediator regulation of TRP channels | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | |||
| Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
| Reactome | TRP channels | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1). Bioorg Med Chem Lett. 2008 Apr 15;18(8):2730-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.